Drug Shortage Report for EFFEXOR XR
| Report ID | 213124 |
| Drug Identification Number | 02237279 |
| Brand name | EFFEXOR XR |
| Common or Proper name | VENLAFAXINE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 37.5MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 90 BT |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-11-15 |
| Estimated end date | Unknown |
| Actual end date | 2023-12-07 |
| Shortage status | Resolved |
| Updated date | 2023-12-19 |
| Company comments | Quality Issue |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-12-19 | French | Compare |
| v3 | 2023-12-19 | English | Compare |
| v2 | 2023-12-13 | French | Compare |
| v1 | 2023-12-13 | English | Compare |
Showing 1 to 4 of 4